Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Longevity Vision Fund: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Longevity Vision Fund
Longevity Vision Fund
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Longevity Vision Fund.
SS
Sourav Sinha
Venture Partner & Head of Innovation
Leadership Team
Key people at Longevity Vision Fund.
Sourav Sinha
Venture Partner & Head of Innovation
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Aug 1, 2022
Senda Biosciences
$120.0M Series C
Flagship Pioneering
Cambridge Innovation Capital
,
Alexandria Venture Investments
,
Bluwave Capital
,
Mayo Clinic
,
Partners Investment
,
Qatar Investment Authority
,
Samsung Life Science Fund
,
Stage 1 Ventures
,
State of Michigan Retirement System
Apr 1, 2022
Tessera Therapeutics
$300.0M Series C
—
Catalio Capital
, Flagship Ventures
,
Petri
,
Abu Dhabi Investment Authority
,
Alaska Permanent Fund
, Altitude Life Science Ventures
,
Cormorant Asset Management
,
Hanwha Impact
,
March Capital
,
SALT Fund
, Vali Barsan
, T. Rowe Price Associates
Jun 11, 2021
Senda Biosciences
$55.0M Series B Extension
—
Alexandria Venture Investments
, Guillaume Pfefer
,
Mayo Clinic
,
Mint Venture Partners
,
Partners Investment
,
Senda Biosciences
,
State of Michigan Retirement System
,
Terra Magnum Capital Partners
Aug 1, 2020
Exo
$40.0M Series B
Action Potential Venture Capital
,
Fiscus Ventures
, Ted Koutouzis MD
Energy Impact Partners
,
Applied Ventures
,
Bold Capital
,
Creative Ventures
,
Innovation Growth Ventures
,
Intel Capital
,
Nautilus Venture Partners
,
OSF Healthcare
, Rising Tide Fund
,
Solasta Ventures
, Anil Achyuta
,
Wanxiang Healthcare Investments
Jun 16, 2020
4D Molecular Therapeutics
$75.0M Series C
Viking Global Investors
Amzak Health
,
ArrowMark Partners
,
Berkeley Catalyst Fund
, BVF Partners
,
Casdin Capital
,
Chiesi Ventures
, Michael Boyle
,
Mirae Asset
,
Octagon Capital
,
Perceptive Advisors
,
QUAD Investment Management
Mar 1, 2020
Sigilon Therapeutics
$80.0M Series B
Flagship Ventures
NanoDimension
,
OrbiMed
,
Polaris Partners
, Timothy A. Springer
, BlackRock
, Eli Lilly and Company
Oct 21, 2019
LyGenesis
$4.0M Other Equity
Greg Bailey
, Sergey Young
—
Aug 1, 2019
Exo
$35.0M Series B
Eric King
9Yards Capital
,
Applied Ventures
,
Bold Capital
,
Creative Ventures
,
Magnetar Capital
,
Nautilus Venture Partners
,
OSF Healthcare
, Rising Tide Fund
,
Sony
,
Wanxiang Healthcare Investments